CAPTRUST Financial Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,038
Closed -$438K 2377
2024
Q3
$438K Sell
24,038
-9,451
-28% -$180K ﹤0.01% 1647
2024
Q2
$582K Buy
33,489
+4,826
+17% +$85.5K ﹤0.01% 1428
2024
Q1
$562K Sell
28,663
-12,696
-31% -$268K ﹤0.01% 1429
2023
Q4
$952K Sell
41,359
-11,912
-22% -$267K ﹤0.01% 1294
2023
Q3
$1.23M Buy
53,271
+2,190
+4% +$55.7K ﹤0.01% 1085
2023
Q2
$1.33M Buy
+51,081
New +$1.35M 0.01% 1025
2022
Q3
Sell
-22
Closed -$1K 3535
2022
Q2
$1K Buy
+22
New +$559 ﹤0.01% 4723

Other funds holding PRVA

CAPTRUST Financial Advisors's PRVA Position: Q4 2024 in Review

CAPTRUST Financial Advisors sold out of Privia Health (PRVA) in Q4 2024, closing a stake of 24,038 shares — an estimated $438K sold.

CAPTRUST Financial Advisors first reported a position in PRVA in Q2 2022 and held it in 7 quarters. The position peaked at $1.33M in Q2 2023. 231 funds tracked by Wall St. Rank hold PRVA as of Q4 2024.

  • CAPTRUST Financial Advisors reported no remaining Privia Health position as of Q4 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 24,038 Privia Health shares in Q4 2024, an estimated $438K.
  • CAPTRUST Financial Advisors first reported a position in Privia Health in Q2 2022 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Privia Health position peaked at $1.33M in Q2 2023.
  • 231 funds tracked by Wall St. Rank held Privia Health as of Q4 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.